CEFADROXIL

N/A

Manufactured by Aurobindo Pharma Limited

6,348 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CEFADROXIL

CEFADROXIL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Aurobindo Pharma Limited. The most commonly reported adverse reactions for CEFADROXIL include PAIN, PNEUMONIA, DRUG HYPERSENSITIVITY, DYSPNOEA, VOMITING. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CEFADROXIL.

Top Adverse Reactions

PAIN307 reports
PNEUMONIA231 reports
DRUG HYPERSENSITIVITY230 reports
DYSPNOEA225 reports
VOMITING217 reports
ASTHMA202 reports
COUGH198 reports
MALAISE191 reports
CHEST PAIN189 reports
OEDEMA160 reports
NASAL OEDEMA150 reports
RESPIRATORY TRACT INFECTION149 reports
WHEEZING148 reports
CHRONIC KIDNEY DISEASE129 reports
FATIGUE121 reports
ACUTE KIDNEY INJURY106 reports
DIARRHOEA105 reports
NAUSEA91 reports
RENAL FAILURE88 reports
HEADACHE85 reports
PRURITUS81 reports
ARTHRALGIA80 reports
RASH74 reports
DRUG INEFFECTIVE73 reports
ERYTHEMA67 reports
BACK PAIN64 reports
ASTHENIA63 reports
PYREXIA62 reports
ANXIETY61 reports
OFF LABEL USE61 reports
DIZZINESS60 reports
URTICARIA56 reports
URINARY TRACT INFECTION55 reports
CELLULITIS53 reports
FALL53 reports
WEIGHT DECREASED52 reports
ANAEMIA51 reports
INFECTION51 reports
INSOMNIA50 reports
PAIN IN EXTREMITY50 reports
CHILLS46 reports
DEATH46 reports
NASOPHARYNGITIS46 reports
THERAPEUTIC PRODUCT CROSS REACTIVITY46 reports
END STAGE RENAL DISEASE45 reports
MYALGIA45 reports
OEDEMA PERIPHERAL44 reports
SINUSITIS42 reports
HYPERTENSION41 reports
DEPRESSION40 reports
OROPHARYNGEAL PAIN38 reports
EMOTIONAL DISTRESS36 reports
GAIT DISTURBANCE35 reports
GASTROINTESTINAL DISORDER35 reports
PERIPHERAL SWELLING35 reports
RHINORRHOEA35 reports
STRESS35 reports
ILLNESS34 reports
OSTEOARTHRITIS34 reports
INFLUENZA33 reports
WEIGHT INCREASED33 reports
COVID 1931 reports
ABDOMINAL DISCOMFORT30 reports
INJURY30 reports
ABDOMINAL PAIN29 reports
CONFUSIONAL STATE29 reports
MIGRAINE29 reports
ABDOMINAL PAIN UPPER28 reports
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS28 reports
NERVOUSNESS28 reports
PRODUCT DOSE OMISSION ISSUE28 reports
ANAPHYLACTIC REACTION27 reports
HYPERSENSITIVITY27 reports
HYPOAESTHESIA27 reports
NEPHROGENIC ANAEMIA27 reports
CONDITION AGGRAVATED26 reports
GASTROOESOPHAGEAL REFLUX DISEASE26 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION26 reports
CONSTIPATION25 reports
DEEP VEIN THROMBOSIS25 reports
GENERAL PHYSICAL HEALTH DETERIORATION25 reports
NASAL CONGESTION25 reports
THROMBOCYTOPENIA25 reports
ANHEDONIA24 reports
BRONCHITIS24 reports
DEHYDRATION24 reports
PULMONARY EMBOLISM24 reports
SCRATCH24 reports
SKIN PLAQUE24 reports
ARTHRITIS23 reports
DECREASED APPETITE23 reports
LOCALISED INFECTION23 reports
ATRIAL FIBRILLATION22 reports
HYPOTENSION22 reports
SECRETION DISCHARGE22 reports
ARTHROPATHY21 reports
DYSPEPSIA21 reports
INJECTION SITE BRUISING21 reports
PARAESTHESIA21 reports
VITAMIN B12 DEFICIENCY21 reports

Report Outcomes

Out of 1,842 classified reports for CEFADROXIL:

Serious 79.4%Non-Serious 20.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1,092 (65.0%)
Male583 (34.7%)
Unknown4 (0.2%)

Reports by Age

Age 65125 reports
Age 6756 reports
Age 6641 reports
Age 7234 reports
Age 6933 reports
Age 5932 reports
Age 6229 reports
Age 7829 reports
Age 7127 reports
Age 7327 reports
Age 5126 reports
Age 6023 reports
Age 7023 reports
Age 5221 reports
Age 6121 reports
Age 4620 reports
Age 5420 reports
Age 6320 reports
Age 4819 reports
Age 5719 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CEFADROXIL?

This profile reflects 6,348 FDA FAERS reports that mention CEFADROXIL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CEFADROXIL?

Frequently reported terms in FAERS include PAIN, PNEUMONIA, DRUG HYPERSENSITIVITY, DYSPNOEA, VOMITING, ASTHMA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CEFADROXIL?

Labeling and FAERS entries often list Aurobindo Pharma Limited in connection with CEFADROXIL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.